All News #Library
Others
Ethris Announces $5M Funding To Prepare ETH47 For Phase 2 Study
18 Jun 2024 //
BUSINESSWIRE
Ethris Initiates First-in-Human Dosing in Phase 1 Study of ETH47
18 Dec 2023 //
GLOBENEWSWIRE
Ethris and Heqet Therapeutics Announce Collaboration
13 Nov 2023 //
GLOBENEWSWIRE
Cipla EU to Invest EUR 15 m in Ethris, initiating a strategic collaboration
30 Dec 2022 //
PR NEWSWIRE
Ethris Announces Collaboration with DIOSynVax and CEPI
21 Dec 2022 //
BUSINESSWIRE
Ethris Raises $26.3M Series B to Advance mRNA-based Therapeutics
01 Feb 2022 //
BUSINESSWIRE

Market Place
Sourcing Support